{"id":"https://openalex.org/W7225634896","doi":"https://doi.org/10.64388/ire1724979","title":"Tofacitinib-Loaded Nanostructured Lipid Carriers: Formulation, Characterization and In Vitro Release","display_name":"Tofacitinib-Loaded Nanostructured Lipid Carriers: Formulation, Characterization and In Vitro Release","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225634896","doi":"https://doi.org/10.64388/ire1724979"},"language":"en","primary_location":{"id":"doi:10.64388/ire1724979","doi":"https://doi.org/10.64388/ire1724979","is_oa":true,"landing_page_url":"https://doi.org/10.64388/ire1724979","pdf_url":"https://www.irejournals.com/formatedpaper/1724979.pdf","source":{"id":"https://openalex.org/S5407000720","display_name":"Iconic Research and Engineering Journals","issn_l":"2456-8880","issn":["2456-8880"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iconic Research and Engineering Journals","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.irejournals.com/formatedpaper/1724979.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161316263","display_name":"Bagam Bhageerath","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bagam Bhageerath","raw_affiliation_strings":["KGR Institute of Technology and Management"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KGR Institute of Technology and Management","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161316686","display_name":"I. Nagaraju","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Nagaraju","raw_affiliation_strings":["Department of Pharmaceutical Sciences , KGR Institute of Technology and Management (KGRITM) , Hyderabad , Telangana , In- dia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , KGR Institute of Technology and Management (KGRITM) , Hyderabad , Telangana , In- dia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161353966","display_name":"G. Ramesh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Ramesh","raw_affiliation_strings":["Department of Pharmaceutical Sciences , KGR Institute of Technology and Management (KGRITM) , Hyderabad , Telangana , In- dia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , KGR Institute of Technology and Management (KGRITM) , Hyderabad , Telangana , In- dia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032742340","display_name":"G. Vijaya Kumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Vijaya Kumar","raw_affiliation_strings":["Department of Pharmaceutical Sciences , KGR Institute of Technology and Management (KGRITM) , Hyderabad , Telangana , In- dia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , KGR Institute of Technology and Management (KGRITM) , Hyderabad , Telangana , In- dia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"5","first_page":"2033","last_page":"2042"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.492900013923645,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.492900013923645,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.31349998712539673,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.12409999966621399,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":1.0},{"id":"https://openalex.org/keywords/nanostructured-lipid-carriers","display_name":"nanostructured lipid carriers","score":1.0},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8289999961853027},{"id":"https://openalex.org/keywords/solid-lipid-nanoparticles","display_name":"solid lipid nanoparticles","score":0.7070000171661377},{"id":"https://openalex.org/keywords/glycerol-monostearate","display_name":"glyceryl monostearate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/oleic-acid","display_name":"oleic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/high-pressure-homogenization","display_name":"high-pressure homogenization","score":0.7440000176429749},{"id":"https://openalex.org/keywords/sonication","display_name":"sonication","score":0.8859999775886536},{"id":"https://openalex.org/keywords/in-vitro-drug-release","display_name":"in vitro drug release","score":0.8379999995231628},{"id":"https://openalex.org/keywords/higuchi-kinetics","display_name":"Higuchi model","score":0.8270000219345093},{"id":"https://openalex.org/keywords/colloidal-stability","display_name":"colloidal stability","score":0.9440000057220459},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.8920000195503235},{"id":"https://openalex.org/keywords/oral-pharmacokinetics","display_name":"oral pharmacokinetics","score":0.9210000038146973},{"id":"https://openalex.org/keywords/drug-delivery-formulation","display_name":"drug delivery formulation","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.8507000207901001},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7139999866485596},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.6517999768257141},{"id":"https://openalex.org/C11432220","wikidata":"https://www.wikidata.org/wiki/Q1975334","display_name":"Dispersity","level":2,"score":0.6381000280380249},{"id":"https://openalex.org/C2781403372","wikidata":"https://www.wikidata.org/wiki/Q207688","display_name":"Oleic acid","level":2,"score":0.588699996471405},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5756999850273132},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5462999939918518},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.48330000042915344},{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.4032000005245209},{"id":"https://openalex.org/C59789625","wikidata":"https://www.wikidata.org/wiki/Q181780","display_name":"Colloid","level":2,"score":0.375},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3747999966144562},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.35589998960494995},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3537999987602234},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.3434999883174896},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.3370000123977661},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.3240000009536743},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.3133000135421753},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.2964000105857849},{"id":"https://openalex.org/C2776330855","wikidata":"https://www.wikidata.org/wiki/Q650187","display_name":"Phosphatidylcholine","level":4,"score":0.27379998564720154},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.26669999957084656},{"id":"https://openalex.org/C2779072430","wikidata":"https://www.wikidata.org/wiki/Q424484","display_name":"Ricinoleic acid","level":3,"score":0.26339998841285706},{"id":"https://openalex.org/C60448018","wikidata":"https://www.wikidata.org/wiki/Q2054937","display_name":"Particle-size distribution","level":3,"score":0.2540000081062317},{"id":"https://openalex.org/C206772107","wikidata":"https://www.wikidata.org/wiki/Q2006868","display_name":"Coulter counter","level":2,"score":0.250900000333786}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64388/ire1724979","doi":"https://doi.org/10.64388/ire1724979","is_oa":true,"landing_page_url":"https://doi.org/10.64388/ire1724979","pdf_url":"https://www.irejournals.com/formatedpaper/1724979.pdf","source":{"id":"https://openalex.org/S5407000720","display_name":"Iconic Research and Engineering Journals","issn_l":"2456-8880","issn":["2456-8880"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iconic Research and Engineering Journals","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.64388/ire1724979","doi":"https://doi.org/10.64388/ire1724979","is_oa":true,"landing_page_url":"https://doi.org/10.64388/ire1724979","pdf_url":"https://www.irejournals.com/formatedpaper/1724979.pdf","source":{"id":"https://openalex.org/S5407000720","display_name":"Iconic Research and Engineering Journals","issn_l":"2456-8880","issn":["2456-8880"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iconic Research and Engineering Journals","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225634896.pdf","grobid_xml":"https://content.openalex.org/works/W7225634896.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2955685025","https://openalex.org/W2223649038","https://openalex.org/W7160094968","https://openalex.org/W7134927135","https://openalex.org/W2486325144","https://openalex.org/W3155551988","https://openalex.org/W7109514660","https://openalex.org/W7215777849","https://openalex.org/W6940133196","https://openalex.org/W7219222509"],"abstract_inverted_index":{"Tofacitinib":[0],"is":[1,221],"an":[2],"orally":[3],"administered":[4],"Janus":[5],"kinase":[6],"inhibitor.":[7],"Nanostructured":[8],"lipid":[9],"carriers":[10],"(NLCs)":[11],"combine":[12],"solid":[13],"and":[14,17,23,38,42,51,73,79,87,95,121,135,158,171,185,190,195,208,223],"liquid":[15],"lipids":[16,37],"may":[18],"alter":[19],"drug":[20,215],"dispersion,":[21],"association":[22],"release":[24,127,212],"in":[25,210],"the":[26,141,145],"gastrointestinal":[27],"environment.":[28],"This":[29],"study":[30],"examined":[31,83],"a":[32,96,106],"tofacitinib-loaded":[33],"NLC":[34,202],"system.":[35],"Candidate":[36],"surfactants":[39],"were":[40,56,59,76,82,101,181,193],"screened,":[41],"five":[43],"batches":[44],"(F1\u2013F5)":[45],"containing":[46],"glyceryl":[47],"monostearate":[48],"(solid":[49],"lipid)":[50,55],"oleic":[52],"acid":[53],"(liquid":[54],"compared.":[57],"Dispersions":[58],"prepared":[60],"by":[61,84],"high-pressure":[62],"homogenization":[63],"and/or":[64],"ultrasonication.":[65],"Particle":[66],"size,":[67,155],"polydispersity":[68],"index":[69],"(PDI),":[70],"zeta":[71,116,159],"potential":[72,117,160],"entrapment":[74,122,156],"efficiency":[75,123,157],"measured;":[77],"compatibility":[78],"solid-state":[80],"behavior":[81],"FTIR,":[85],"DSC":[86],"XRD.":[88],"In":[89],"vitro":[90,211],"release,":[91],"three-month":[92],"colloidal":[93,206],"stability":[94],"summarized":[97],"oral":[98],"pharmacokinetic":[99,219],"comparison":[100],"evaluated.":[102],"Batch":[103],"F5":[104,134],"showed":[105],"mean":[107],"particle":[108,154],"size":[109],"of":[110,114,118,124],"118.5":[111,163],"nm,":[112,166],"PDI":[113],"0.198,":[115],"\u221232.1":[119,173],"mV":[120],"88.9%.":[125],"Cumulative":[126],"at":[128],"24":[129],"h":[130],"was":[131,216],"96.5%":[132],"for":[133,137],"82.1%":[136],"pure":[138,214],"drug,":[139],"with":[140,204,226],"Higuchi":[142],"model":[143],"giving":[144],"best":[146],"fit":[147],"(R\u00b2":[148],"=":[149],"0.987).":[150],"After":[151],"three":[152],"months,":[153],"changed":[161],"from":[162,167,172],"to":[164,169,174],"125.2":[165],"88.9%":[168],"86.7%":[170],"\u221230.4":[175],"mV,":[176],"respectively.":[177],"Reported":[178],"Cmax":[179],"values":[180,192],"3.9":[182],"\u00b5g/mL":[183,187],"(NLC)":[184],"1.8":[186],"(pure":[188],"drug),":[189],"AUC":[191],"29.8":[194],"12.4":[196],"(units":[197],"not":[198],"stated).":[199],"A":[200],"tofacitinib-containing":[201],"dispersion":[203],"favorable":[205],"properties":[207],"greater":[209],"than":[213],"prepared.":[217],"The":[218],"difference":[220],"preliminary":[222],"requires":[224],"confirmation":[225],"complete,":[227],"dose-normalized":[228],"data.":[229]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}